These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9607185)

  • 1. Antisense oligodesoxynucleotide strategies in renal and cardiovascular disease.
    Haller H; Maasch C; Dragun D; Wellner M; von Janta-Lipinski M; Luft FC
    Kidney Int; 1998 Jun; 53(6):1550-8. PubMed ID: 9607185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation.
    Dragun D; Tullius SG; Park JK; Maasch C; Lukitsch I; Lippoldt A; Gross V; Luft FC; Haller H
    Kidney Int; 1998 Aug; 54(2):590-602. PubMed ID: 9690227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat.
    Haller H; Dragun D; Miethke A; Park JK; Weis A; Lippoldt A; Gross V; Luft FC
    Kidney Int; 1996 Aug; 50(2):473-80. PubMed ID: 8840275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diapedesis of leukocytes: antisense oligonucleotides for rescue.
    Dragun D; Haller H
    Exp Nephrol; 1999; 7(2):185-92. PubMed ID: 10213872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antisense oligodeoxynucleotides for ICAM-1 on renal ischaemia-reperfusion injury in the anaesthetised rat.
    Kiew LV; Munavvar AS; Law CH; Azizan AN; Nazarina AR; Sidik K; Johns EJ
    J Physiol; 2004 Jun; 557(Pt 3):981-9. PubMed ID: 15047774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat.
    Dragun D; Lukitsch I; Tullius SG; Qun Y; Park JK; Schneider W; Luft FC; Haller H
    Kidney Int; 1998 Dec; 54(6):2113-22. PubMed ID: 9853277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases.
    Tomita N; Morishita R
    Curr Pharm Des; 2004; 10(7):797-803. PubMed ID: 15032704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
    Wang XY; Repasky E; Liu HT
    Exp Cell Res; 1999 Jul; 250(1):253-63. PubMed ID: 10388539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.
    Chen CC; Wang JK; Lin SB
    J Immunol; 1998 Dec; 161(11):6206-14. PubMed ID: 9834107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
    Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
    Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
    Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
    Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects of antisense oligodeoxynucleotides to alleviate renal ischaemia-reperfusion injury.
    Matsuyama M; Yoshimura R
    Expert Opin Biol Ther; 2004 Dec; 4(12):1931-7. PubMed ID: 15571455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
    Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
    Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.
    Bennett CF; Condon TP; Grimm S; Chan H; Chiang MY
    J Immunol; 1994 Apr; 152(7):3530-40. PubMed ID: 7511650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotide knockdown of mGlu₅ receptor attenuates the antinociceptive tolerance and up-regulated expression of spinal protein kinase C associated with chronic morphine treatment.
    Xu T; Chen M; Zhou Q; Xue Y; Wang L; Bil De Arce VJ; Zhang X; Jiang W
    Eur J Pharmacol; 2012 May; 683(1-3):78-85. PubMed ID: 22429573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.
    Miele ME; Bennett CF; Miller BE; Welch DR
    Exp Cell Res; 1994 Sep; 214(1):231-41. PubMed ID: 7915992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease.
    Phillips MI; Galli SM; Mehta JL
    Drugs; 2000 Aug; 60(2):239-48. PubMed ID: 10983731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the biological activity of anti-ICAM-1 oligonucleotides complexed to non-viral carriers.
    Lucas B; Van Rompaey E; Remaut K; Sanders N; De Smedt SC; Demeester J
    J Control Release; 2004 Apr; 96(1):207-19. PubMed ID: 15063042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
    Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
    Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of intercellular adhesion molecule-1 antisense oligonucleotides using a topical hydrogel tissue sealant in a murine partial nephrectomy/ischemia model.
    Phull H; Lien YH; Salkini MW; Escobar C; Lai LW; Ramakumar S
    Urology; 2008 Sep; 72(3):690-5. PubMed ID: 18336877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.